Facioscapulohumeral muscular dystrophy (FSHD): An enigma unravelled?

Human Genetics

Volumn 131, Issue 3, 2012, Pages 325-340

  Richards, Mark ^a   Coppée, Frédérique ^b   Thomas, Nick ^a   Belayew, Alexandra ^b   Upadhyaya, Meena ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MONS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE HOMEOBOX 4; HETEROCHROMATIN PROTEIN 1; HOMEODOMAIN PROTEIN; MESSENGER RNA; MICROSATELLITE DNA; MYOD PROTEIN; TRANSCRIPTION FACTOR CTCF; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7; UNCLASSIFIED DRUG; DUX4 PROTEIN, HUMAN; FRG2 PROTEIN, HUMAN; NUCLEAR PROTEIN;

ABDOMINAL WALL MUSCULATURE; CHROMATIN STRUCTURE; CLINICAL FEATURE; DNA METHYLATION; DNA REPLICATION; EPIGENETICS; EPILEPSY; FACE MUSCLE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FOOT DROP; GAIN OF FUNCTION MUTATION; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HEARING LOSS; HEART MUSCLE CONDUCTION DISTURBANCE; HISTONE MODIFICATION; HOMEOBOX; HUMAN; LEARNING DISORDER; LEG MUSCLE; MOLECULAR DIAGNOSIS; MUSCLE WEAKNESS; MUSCULOSKELETAL DISEASE; ONSET AGE; OPEN READING FRAME; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETINAL TELANGIECTASIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCAPULA; SCAPULAR FIXATION; SEQUENCE ANALYSIS; SHOULDER; TREATMENT INDICATION; GENETIC EPIGENESIS; GENETICS;

EPIGENESIS, GENETIC; HOMEODOMAIN PROTEINS; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; NUCLEAR PROTEINS; SEQUENCE DELETION;

EID: 84859514536     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-011-1100-z     Document Type: Review

References (98)

1. Alexiadis V, Ballestas ME, Sanchez C, Winokur S, Vedanarayanan V, Warren M, Ehrlich M (2007) RNAPol-ChIP analysis of transcription from FSHD-linked tandem repeats and satellite DNA. Biochim Biophys Acta 1769:29-40
2. Ansseau E, Laoudj-Chenivesse D, Marcowycz A, Tassin A, Vanderplanck C, Sauvage S, Barro M, Mahieu I, Leroy A, Leclercq I, Mainfroid V, Figlewicz D, Mouly V, Butler-Browne G, Belayew A, Coppée F (2009) DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS One 4:e7482
3. Arashiro P, Eisenberg I, Kho AT, Cerqueira AM, Canovas M, Silva HC, Pavanello RC, Verjovski-Almeida S, Kunkel LM, Zatz M (2009) Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers. Proc Natl Acad Sci USA 106:6220-6225
4. Ballestar E, Wolffe AP (2001) Methyl-CpG-binding proteins: targeting specific gene repression. Eur J Biochem 268:1-6
5. Barro M, Carnac G, Flavier S, Mercier J, Vassetzky Y, Laoudj-Chenivesse D (2010) Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects. J Cell Mol Med 14:275-289
6. Beckers M, Gabriëls J, van der Maarel S, De Vriese A, Frants RR, Collen D, Belayew A (2001) Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements. Gene 264:51-57
7. Belayew A (2010) Cascade of gene activation in Landouzy Dejerine muscular dystrophy. Bull Mem Acad R Med Belg 165:87-97
8. Bickmore WA, van der Maarel SM (2003) Perturbations of chromatin structure in human genetic disease: recent advances. Hum Mol Genet 12:R207-R213
9. Biressi S, Rando TA (2010) Heterogeneity in the muscle satellite cell population. Semin Cell Dev Biol 21:845-854
10. Bortolanza S, Nonis A, Sanvito F, Maciotta S, Sitia G, Wei J, Torrente Y, Di Serio C, Chamberlain JR, Gabellini D (2011) AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy. Mol Ther [Epub ahead of print]. doi:10.1038/mt.2011.153
11. Bosnakovski D, Lamb S, Simsek T, Xu Z, Belayew A, Perlingeiro R, Kyba M (2008a) DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Exp Neurol 214:87-96
12. Bosnakovski D, Xu Z, Gang EJ, Galindo CL, Liu M, Simsek T, Garner HR, Agha-Mohammadi S, Tassin A, Coppée F, Belayew A, Perlingeiro RR, Kyba M (2008b) An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J 27:2766-2779
13. Buckingham M, Bajard L, Chang T, Daubas P, Hadchouel J, Meilhac S, Montarras D, Rocancourt D, Relaix F (2003) The formation of skeletal muscle: from somite to limb. J Anat 202:59-68
14. Chen SC, Frett E, Marx J, Bosnakovski D, Reed X, Kyba M, Kennedy BK (2011) Decreased proliferation kinetics of mouse myoblasts overexpressing FRG1. PLoS One 6:e19780
15. Clapp J, Mitchell LM, Bolland DJ, Fantes J, Corcoran AE, Scotting PJ, Armour JA, Hewitt JE (2007) Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am J Hum Genet 81:264-279
16. de Greef JC, Wohlgemuth M, Chan OA, Hansson KB, Smeets D, Frants RR, Weemaes CM, Padberg GW, van der Maarel SM (2007) Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD. Neurology 69:1018-1026
17. de Greef JC, Lemmers RJ, van Engelen BG, Sacconi S, Venance SL, Frants RR, Tawil R, van der Maarel SM (2009) Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD. Hum Mutat 30:1449-1459
18. de Greef JC, Lemmers RJ, Camaño P, Day JW, Sacconi S, Dunand M, van Engelen BG, Kiuru-Enari S, Padberg GW, Rosa AL, Desnuelle C, Spuler S, Tarnopolsky M, Venance SL, Frants RR, van der Maarel SM, Tawil R (2010) Clinical features of facioscapulohumeral muscular dystrophy 2. Neurology 75:1548-1554
19. Deak KL, Lemmers RJ, Stajich JM, Klooster R, Tawil R, Frants RR, Speer MC, van der Maarel SM, Gilbert JR (2007) Genotypephenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4. Neurology 68:578-582
20. Deidda G, Cacurri S, Grisanti P, Vigneti E, Piazzo N, Felicetti L (1995) Physical mapping evidence for a duplicated region on chromosome 10qter showing high homology with the facioscapulohumeral muscular dystrophy locus on chromosome 4qter. Eur J Hum Genet 3:155-167
21. Ding H, Beckers MC, Plaisance S, Marynen P, Collen D, Belayew A (1998) Characterization of a double homeodomain protein (DUX1) Encoded by a cDNA Homologous to 3.3 Kb dispersed repeated elements. Hum Mol Genet 7:1681-1694
22. Dirks-Naylor AJ, Lennon-Edwards S (2011) Cellular and molecular mechanisms of apoptosis in age-related muscle atrophy. Curr Aging Sci [Epub ahead of print]
23. Dixit M, Ansseau E, Tassin A, Winokur S, Shi R, Qian H, Sauvage S, Mattéotti C, van Acker AM, Leo O, Figlewicz D, Barro M, Laoudj-Chenivesse D, Belayew A, Coppée F, Chen YW (2007) DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci USA 104:18157-18162
24. Gabellini D, Green MR, Tupler R (2002) Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110:339-348
25. Gabellini D, D'Antona G, Moggio M, Prelle A, Zecca C, Adami R, Angeletti B, Ciscato P, Pellegrino MA, Bottinelli R, Green MR, Tupler R (2006) Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 439:973-977
26. Gabriëls J, Beckers MC, Ding H, De Vriese A, Plaisance S, van der Maarel SM, Padberg GW, Frants RR, Hewitt JE, Collen D, Belayew A (1999) Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 236:25-32
27. Gehring WJ (1993) Exploring the homeobox. Gene 135:215-221
28. Gilbert JR, Stajich JM, Wall S, Carter SC, Qiu H, Vance JM, Stewart CS, Speer MC, Pufky J, Yamaoka LH, Rozear M, Samson F, Fardeau M, Roses AD, Pericak-Vance MA (1993) Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD). Am J Hum Genet 53:401-408
29. Hanel ML, Wuebbles RD, Jones PL (2009) Muscular dystrophy candidate gene FRG1 is critical for muscle development. Dev Dyn 238:1502-1512
30. Hewitt JE, Lyle R, Clark LN, Valleley EM, Wright TJ, Wijmenga C, van Deutekom J, Francis F, Sharpe PT, Hofker M, Frants RR, Williamson R (1994) Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet 3:1287-1295
31. Jiang G, Yang F, van Overveld PG, Vedanarayanan V, van der Maarel S, Ehrlich M (2003) Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum Mol Genet 12:2909-2921
32. Kawamura-Saito M, Yamazaki Y, Kaneko K, Kawaguchi N, Kanda H, Mukai H, Gotoh T, Motoi T, Fukayama M, Aburatani H, Takizawa T, Nakamura T (2006) Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet 15:2125-2137
33. Klooster R, Straasheijm K, Shah B, Sowden J, Frants R, Thornton C, Tawil R, van der Maarel S (2009) Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level. Eur J Hum Genet 17:1615-1624
34. Kondo T, Bobek MP, Kuick R, Lamb B, Zhu X, Narayan A, Bourc'his D, Viegas-Pequignot E, Ehrlich M, Hanash SM (2000) Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. Hum Mol Genet 9:597-604
35. Kowaljow V, Marcowycz A, Ansseau E, Conde CB, Sauvage S, Mattéotti C, Arias C, Corona ED, Nuñez NG, Leo O, Wattiez R, Figlewicz D, Laoudj-Chenivesse D, Belayew A, Coppée F, Rosa AL (2007) The DUX4 gene at the FSHD1A locus encodes a proapoptotic protein. Neuromuscul Disord 17:611-623
36. Lachner M, O'Sullivan RJ, Jenuwein T (2003) An epigenetic road map for histone lysine methylation. J Cell Sci 116:2117-2124
37. Laforêt P, de Toma C, Eymard B, Becane HM, Jeanpierre M, Fardeau M, Duboc D (1998) Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy. Neurology 51:1454-1456
38. Laoudj-Chenivesse D, Carnac G, Bisbal C, Hugon G, Bouillot S, Desnuelle C, Vassetzky Y, Fernandez A (2005) Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle. J Mol Med 83:216-224
39. Lemmers RJL, de Kievit P, van Geel M, van der Wielen MJ, Bakker E, Padberg GW, Frants RR, van der Maarel SM (2001) Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis. Ann Neurol 50:816-819
40. Lemmers RJ, de Kievit P, Sandkuijl L, Padberg GW, van Ommen GJ, Frants RR, van der Maarel SM (2002) Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere. Nat Genet 32:235-236
41. Lemmers RJ, Van Overveld PG, Sandkuijl LA, Vrieling H, Padberg GW, Frants RR, van der Maarel SM (2004) Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy. Am J Hum Genet 75:44-53
42. Lemmers RJ, van der Vliet PJ, van der Gaag KJ, Zuniga S, Frants RR, de Knijff P, van der Maarel SM (2010a) Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution. Am J Hum Genet 86:364-377
43. Lemmers RJ, van der Vliet PJ, Klooster R, Sacconi S, Camaño P, Dauwerse JG, Snider L, Straasheijm KR, van Ommen GJ, Padberg GW, Miller DG, Tapscott SJ, Tawil R, Frants RR, van der Maarel SM (2010b) A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329:1650-1653
44. Liu DX, Lobie PE (2007) Transcriptional activation of p53 by Pitx1. Cell Death Differ 14:1893-1907
45. Liu Q, Jones TI, Tang VW, Brieher WM, Jones PL (2010) Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites. J Cell Sci 123:1116-1123
46. Lunt PW (1998) 44th ENMC international workshop: facioscapulohumeral muscular dystrophy: molecular studies 19-21 July 1996, Naarden, The Netherlands. Neuromuscul Disord 8:126-30
47. Lunt PW, Jardine PE, Koch MC, Maynard J, Osborn M, Williams M, Harper PS, Upadhyaya M (1995) Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Genet 4:951-958
48. Lyle R, Wright TJ, Clark LN, Hewitt JE (1995) The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeoboxcontaining repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes. Genomics 28:389-397
49. Maddocks OD, Vousden KH (2011) Erratum to: Metabolic regulation by p53. J Mol Med 89:531
50. Masny PS, Chan OY, de Greef JC, Bengtsson U, Ehrlich M, Tawil R, Lock LF, Hewitt JE, Stocksdale J, Martin JH, van der Maarel SM, Winokur ST (2010) Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei. Eur J Hum Genet 18:448-456
51. Matsumura T, Goto K, Yamanaka G, Lee JH, Zhang C, Hayashi YK, Arahata K (2002) Chromosome 4q:10q translocations; comparison with different ethnic populations and FSHD patients. BMC Neurol 2:7
52. Nguyen K, Walrafen P, Bernard R, Attarian S, Chaix C, Vovan C, Renard E, Dufrane N, Pouget J, Vannier A, Bensimon A, Lévy N (2011) Molecular combing reveals allelic combinations in facioscapulohumeral dystrophy. Ann Neurolog. Accepted manuscript online: 7 JUN 2011 01:19PM EST | (in press). doi: 10.1002/ana.22513
53. Osborne RJ, Welle S, Venance SL, Thornton CA, Tawil R (2007) Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology 68:569-577
54. Ottaviani A, Rival-Gervier S, Boussouar A, Foerster AM, Rondier D, Sacconi S, Desnuelle C, Gilson E, Magdinier F (2009) The D4Z4 macrosatellite repeat acts as a CTCF and A-type laminsdependent insulator in facio-scapulo-humeral dystrophy. PLoS Genet 5:e1000394
55. Ottaviani A, Schluth-Bolard C, Gilson E, Magdinier F (2010) D4Z4 as a prototype of CTCF and lamins-dependent insulator in human cells. Nucleus 1:30-36
56. Padberg GW (2004) Facioscapulohumeral muscular dystrophy: a clinician's experience. In: Upadhyaya M, Cooper DN (eds) Facioscapulohumeral muscular dystrophy: clinical medicine and molecular cell biology. Garland Science/BIOS Scientific, Abingdon, pp 41-54
57. Padberg GW, Brouwer OF, de Keizer RJ, Dijkman G, Wijmenga C, Grote JJ, Frants RR (1995) On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy. Muscle Nerve 2:S73-S80
58. Peterson CL, Laniel MA (2004) Histones and histone modifications. Curr Biol 14:R546-R551
59. Petrov A, Pirozhkova I, Carnac G, Laoudj D, Lipinski M, Vassetzky YS (2006) Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts. Proc Natl Acad Sci 103:6982-6987
60. Petrov A, Allinne J, Pirozhkova I, Laoudj D, Lipinski M, Vassetzky YS (2008) A nuclear matrix attachment site in the 4q35 locus has an enhancer-blocking activity in vivo: implications for facioscapulohumeral dystrophy. Genome Res 18:39-45
61. Reed PW, Corse AM, Porter NC, Flanigan KM, Bloch RJ (2007) Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy. Exp Neurol 205:583-586
62. Saccone V, Puri PL (2010) Epigenetic regulation of skeletal myogenesis. Organogenesis 6:48-53
63. Saito Y, Miyashita S, Yokoyama A, Komaki H, Seki A, Maegaki Y, Ohno K (2007) Facioscapulohumeral muscular dystrophy with severe mental retardation and epilepsy. Brain Dev 29:231-233
64. Sandri M, El Meslemani AH, Sandri C, Schjerling P, Vissing K, Andersen JL, Rossini K, Carraro U, Angelini C (2001) Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo-humeral muscular dystrophy. A potential target for pharmacological treatment? J Neuropathol Exp Neurol 60:302-312
65. Schwarzkopf M, Coletti D, Marazzi G, Sassoon D (2008) Chronic p53 activity leads to skeletal muscle atrophy and muscle stem cell perturbation. Basic Appl Myol 18:131-138
66. Snider L, Asawachaicharn A, Tyler AE, Geng LN, Petek LM, Maves L, Miller DG, Lemmers RJ, Winokur ST, Tawil R, van der Maarel SM, Filippova GN, Tapscott SJ (2009) RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum Mol Genet 18:2414-2430
67. Snider L, Geng LN, Lemmers RJ, Kyba M, Ware CB, Nelson AM, Tawil R, Filippova GN, van der Maarel SM, Tapscott SJ, Miller DG (2010) Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet 6:e1001181
68. Spurlock G, Jim HP, Upadhyaya M (2010) Confirmation that the specific SSLP microsatellite allele 4qA161 segregates with fascioscapulohumeral muscular dystrophy (FSHD) in a cohort of multiplex and simplex FSHD families. Muscle Nerve 42:820-821
69. Stadler G, Chen JC, Wagner K, Robin JD, Shay JW, Emerson CP Jr, Wright WE (2011) Establishment of clonal myogenic cell lines from severely affected dystrophic muscles-CDK4 maintains the myogenic population. Skelet Muscle 1:12
70. Sun CY, van Koningsbruggen S, Long SW, Straasheijm K, Klooster R, Jones TI, Bellini M, Levesque L, Brieher WM, van der Maarel SM, Jones PL (2011) Facioscapulohumeral muscular dystrophy region gene 1 is a dynamic RNA-associated and actinbundling protein. J Mol Biol 12:397-416
71. Tawil R (2008) Facioscapulohumeral muscular dystrophy. Neurotherapeutics 5:601-606
72. Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M, King W, Weiffenbach B, Figelwicz D, Group FSH-DY (1996) Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. Ann Neurol 39:744-748
73. Thomas NST, Wiseman K, Spurlock G, MacDonald M, Üstek D, Upadhyaya M (2007) A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere. J Med Genet 44:215-218
74. Tupler R, Berardinelli A, Barbierato L, Frants R, Hewitt JE, Lanzi G, Maraschio P, Tiepolo L (1996) Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy. J Med Genet 33:366-370
75. Tupler R, Perini G, Pellegrino MA, Green MR (1999) Profound misregulation of muscle-specific gene expression in facioscapulohumeral muscular dystrophy. Proc Natl Acad Sci USA 96:12650-12654
76. Upadhyaya M, Cooper DN (2004) Facioscapulohumeral muscular dystrophy: clinical medicine and molecular cell biology. Garland Science/BIOS Scientific, Abingdon
77. Upadhyaya M, Lunt PW, Sarfarazi M, Broadhead W, Daniels J, Owen M, Harper PS (1990) DNA marker applicable to presymptomatic and prenatal diagnosis of facioscapulohumeral disease. Lancet 336:1320-1321
78. van Deutekom JC, Bakker E, Lemmers RJ, van der Wielen MJ, Bik E, Hofker MH, Padberg GW, Frants RR (1996) Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counselling and the etiology of FSHD1. Hum Mol Genet 5:1997-2003
79. van Geel M, Dickson MC, Beck AF, Bolland DJ, Frants RR, van der Maarel SM, de Jong PJ, Hewitt JE (2002) Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin. Genomics 79:210-217
80. van Koningsbruggen S, Straasheijm KR, Sterrenburg E, de Graaf N, Dauwerse HG, Frants RR, van der Maarel SM (2007) FRG1Pmediated aggregation of proteins involved in pre-mRNA processing. Chromosoma 116:53-64
81. van Overveld PG, Lemmers RJ, Sandkuijl LA, Enthoven L, Winokur ST, Bakels F, Padberg GW, van Ommen GJ, Frants RR, van der Maarel SM (2003) Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet 35:315-317
82. van Overveld PG, Enthoven L, Ricci E, Rossi M, Felicetti L, Jeanpierre M, Winokur ST, Frants RR, Padberg GW, van der Maarel SM (2005) Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy. Ann Neurol 58:569-576
83. Wallace LM, Garwick SE, Mei W, Belayew A, Coppee F, Ladner KJ, Guttridge D, Yang J, Harper SQ (2010) DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol 69:540-552
84. Wallace LM, Garwick SE, Tupler R, Harper SQ (2011) RNA interference improves myopathic phenotypes in mice overexpressing FSHD region Gene 1 (FRG1). Mol Ther [Epub ahead of print]
85. Wijmenga C, Frants RR, Brouwer OF, Moerer P, Weber JL, Padberg GW (1990) Location of the facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 336:651-653
86. Wijmenga C, Hewitt JE, Sandkuijl LA, Clark LN, Wright TJ, Dauwerse HG, Gruter A, Hofker MH, Moerer P, Williamson R, van Ommen GB, Padberg GW, Frants RR (1992) Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 2:26-30
87. Winokur ST, Bengtsson U, Feddersen J, Mathews KD, Weiffenbach B, Bailey H, Markovich RP, Murray JC, Wasmuth JJ, Altherr MR (1994) The DNA rearrangement associated with facioscapulohumeral muscular dystrophy involves a heterochromatinassociated repetitive element: implications for a role of chromatin structure in the pathogenesis of the disease. Chromosome Res 2:225-234
88. Winokur ST, Bengtsson U, Vargas JC, Wasmuth JJ, Altherr MR (1996) The evolutionary distribution and structural organization of the homeobox-containing repeat D4Z4 indicates a functional role for the ancestral copy in the FSHD region. Hum Mol Genet 5:1567-1575
89. Winokur ST, Chen YW, Masny PS, Martin JH, Ehmsen JT, Tapscott SJ, van der Maarel SM, Hayashi Y, Flanigan KM (2003a) Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum Mol Genet 12:2895-2907
90. Winokur ST, Barrett K, Martin JH, Forrester JR, Simon M, Tawil R, Chung SA, Masny PS, Figlewicz DA (2003b) Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul Disord 13:322-333
91. Wohlgemuth M, van der Kooi EL, van Kesteren RG, van der Maarel SM, Padberg GW (2004) Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology 63:176-178
92. Wuebbles RD, Hanel ML, Jones PL (2009) FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy. Dis Model Mech 2:267-274
93. Wuebbles RD, Long SW, Hanel ML, Jones PL (2010) Testing the effects of FSHD candidate gene expression in vertebrate muscle development. Int J Clin Exp Pathol 3:386-400
94. Yang F, Shao C, Vedanarayanan V, Ehrlich M (2004) Cytogenetic and immuno-FISH analysis of the 4q subtelomeric region that is associated with facioscapulohumeral muscular dystrophy. Chromosoma 112:350-359
95. Yip DJ, Picketts DJ (2003) Increasing D4Z4 repeat copy number compromises C2C12 myoblast differentiation. FEBS Lett 537: 133-138
96. Zeng W, de Greef JC, Chen YY, Chien R, Kong X, Gregson HC, Winokur ST, Pyle A, Robertson KD, Schmiesing JA, Kimonis VE, Balog J, Frants RR, Ball AR Jr, Lock LF, Donovan PJ, van der Maarel SM, Yokomori K (2009) Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS Genet 5:e1000559
97. Zhang XY, Wang R, Ehrlich M (1985) Human DNA sequene exhibiting gamete-speeille hypomethylatlon. Nucl Acids Res 13:4837-4851
98. Zhang Y, Forner J, Fournet S, Jeanpierre M (2001) Improved characterization of FSHD mutations. Ann Genet 44:105-110